High-throughput alternative splicing quantification by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Authors:
- Charles R. CantorCCCharles R. Cantor
- Chunming DingCDChunming Ding
Open Access
- 1 January 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 33 (11) , e99
Abstract
Alternative splicing is a significant contributor to transcriptome diversity, and a high-throughput experimental method to quantitatively assess predictions from expressed sequence tag and microarray analyses may help to answer questions about the extent and functional significance of these variants. Here, we describe a method for high-throughput analysis of known or suspected alternative splicing variants (ASVs) using PCR, primer extension and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Reverse-transcribed mRNA is PCR amplified with primers surrounding the site of alternative splicing, followed by a primer extension reaction designed to target sequence disparities between two or more variants. These primer extension products are assayed on a MALDI-TOF mass spectrometer and analyzed automatically. This method is high-throughput, highly accurate and reproducible, allowing for the verification of the existence of splicing variants in a variety of samples. An example given also demonstrates how this method can eliminate potential pitfalls from ordinary gel electrophoretic analysis of splicing variants where heteroduplexes formed from different variants can produce erroneous results. The new method can be used to create alternative variant profiles for cancer markers, to study complex splicing regulation, or to screen potential splicing therapies.Keywords
This publication has 40 references indexed in Scilit:
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical reviewBritish Journal of Haematology, 2005
- αCP-4, Encoded by a Putative Tumor Suppressor Gene at 3p21, But Not Its Alternative Splice Variant αCP-4a, Is Underexpressed in Lung CancerCancer Research, 2004
- Alternative splice variant of actinin-4 in small cell lung cancerOncogene, 2004
- Identification of alternatively spliced mRNA variants related to cancers by genome-wide ESTs alignmentOncogene, 2004
- Single Molecule Profiling of Alternative Pre-mRNA SplicingScience, 2003
- A genomic view of alternative splicingNature Genetics, 2002
- Regulation of the fibronectin EDA exon alternative splicing. Cooperative role of the exonic enhancer element and the 5′ splicing siteFEBS Letters, 1998
- Identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblastsPlacenta, 1994
- Split genes and RNA splicingCell, 1994